{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:23:17Z","timestamp":1791912197700,"version":"4.3.4"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.jaad.2013.11.015","type":"journal-article","created":{"date-parts":[[2014,1,2]],"date-time":"2014-01-02T17:15:23Z","timestamp":1388682923000},"page":"539-548","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":104,"title":["Generalized bullous fixed drug eruption is distinct from Stevens-Johnson syndrome\/toxic epidermal necrolysis by immunohistopathological features"],"prefix":"10.1016","volume":"70","author":[{"given":"Yung-Tsu","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jheng-Wei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Ying","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Hsiang","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hung","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Yu","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2013.11.015_bib1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1610-0387.2007.06491.x","article-title":"Fixed drug eruption: state of the art","volume":"6","author":"Ozkaya","year":"2006","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaad.2013.11.015_bib2","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/j.1365-4632.2006.02853.x","article-title":"Fixed drug eruption (FDE): changing scenario of incriminating drugs","volume":"45","author":"Sehgal","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2013.11.015_bib3","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0091-6749(03)01624-5","article-title":"IFN-gamma-producing effector CD8+ T\u00a0cells and IL-10-producing regulatory CD4+ T cells in fixed drug eruption","volume":"112","author":"Teraki","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2013.11.015_bib4","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/j.1365-2133.2008.08516.x","article-title":"In\u00a0vivo dynamics of intraepidermal CD8+ T cells and CD4+ T cells during the evolution of fixed drug eruption","volume":"158","author":"Mizukawa","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2013.11.015_bib5","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1365-2133.2005.07057.x","article-title":"Possible role of Fas\/Fas ligand\u2013mediated apoptosis in the pathogenesis of fixed drug eruption","volume":"154","author":"Choi","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2013.11.015_bib6","first-page":"201","article-title":"Fixed drug eruption: a disease mediated by self-inflicted responses of intraepidermal T cells","volume":"17","author":"Shiohara","year":"2007","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2013.11.015_bib7","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2230.2009.03622.x","article-title":"Nonpigmenting fixed drug eruption as a possible abortive variant of toxic epidermal necrolysis: immunohistochemical and serum cytokine analyses","volume":"35","author":"Mizukawa","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2013.11.015_bib8","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1001\/archderm.138.8.1019","article-title":"Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis","volume":"138","author":"Auquier-Dunant","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2013.11.015_bib9","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1126\/science.282.5388.490","article-title":"Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin","volume":"282","author":"Viard","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.jaad.2013.11.015_bib10","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1046\/j.1523-1747.2002.01622.x","article-title":"Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis","volume":"118","author":"Nassif","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2013.11.015_bib11","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/nm.1884","article-title":"Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"14","author":"Chung","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.jaad.2013.11.015_bib12","doi-asserted-by":"crossref","first-page":"514","DOI":"10.7326\/0003-4819-151-7-200910060-00016","article-title":"Granulysin as a marker for early diagnosis of the Stevens-Johnson syndrome","volume":"151","author":"Abe","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2013.11.015_bib13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jaad.2010.04.042","article-title":"Rapid immunochromatographic test for serum granulysin is useful for the prediction of Stevens-Johnson syndrome and\u00a0toxic epidermal necrolysis","volume":"65","author":"Fujita","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.11.015_bib14","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/bjd.12133","article-title":"Prognosis of generalized bullous fixed drug eruption: comparison with Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"168","author":"Lipowicz","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2013.11.015_bib15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.dsi.2012.02.002","article-title":"Fixed-drug eruption: a retrospective study in a single referral center in northern Taiwan","volume":"30","author":"Lee","year":"2012","journal-title":"Dermatologica Sinica"},{"key":"10.1016\/j.jaad.2013.11.015_bib16","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme","volume":"169","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2013.11.015_bib17","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1002\/eji.200323977","article-title":"Granulysin in human serum as a marker of cell-mediated immunity","volume":"33","author":"Ogawa","year":"2003","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaad.2013.11.015_bib18","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/ajh.20570","article-title":"Analysis of serum granulysin in patients with hematopoietic stem-cell transplantation: its usefulness as a marker of graft-versus-host reaction","volume":"81","author":"Nagasawa","year":"2006","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jaad.2013.11.015_bib19","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1365-2133.2012.10921.x","article-title":"Prolonged elevation of serum granulysin in drug-induced hypersensitivity syndrome","volume":"167","author":"Saito","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2013.11.015_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1346-8138.2012.01532.x","article-title":"Distinguishing between erythema multiforme major and Stevens-Johnson syndrome\/toxic epidermal necrolysis immunopathologically","volume":"39","author":"Iwai","year":"2012","journal-title":"J Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096221301270X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096221301270X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:30:55Z","timestamp":1759271455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019096221301270X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S019096221301270X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2013.11.015","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generalized bullous fixed drug eruption is distinct from Stevens-Johnson syndrome\/toxic epidermal necrolysis by immunohistopathological features","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2013.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}